EP3415139
GJÖF BENSÓDÍASEPÍNS
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
13.6.2012EP published:
6.4.2022EP application number:
18171484.1
EP translation filed:
31.5.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
12.6.2032Expiry date:
12.6.2026Next due date:
30.6.2026
Title in English:
ADMINISTRATION OF BENZODIAZEPINELanguage of the patent:
English
Timeline
Today
13.6.2012EP application
6.4.2022EP Publication
31.5.2022Translation submitted
15.7.2022Registration published
12.6.2026Expires
Owner
Name:
Neurelis, Inc.Address:
12390 El Camino Real Suite 170, San Diego, CA 92130, US
Inventor
Name:
CARTT, SteveAddress:
Union City, CA 94587, US
Name:
MEDEIROS, DavidAddress:
South San Francisco, CA 94080, US
Name:
GWOZDZ, Garry ThomasAddress:
Jim Thorpe, PA 18229, US
Name:
LOXLEY, AndrewAddress:
Philadelphia, PA 19106, US
Name:
MITCHNICK, MarkAddress:
East Hampton, NY 11937, US
Name:
HALE, DavidAddress:
San Diego, CA 92130, US
Name:
MAGGIO, Edward T.Address:
San Diego, CA 92128, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201161497017 PDate:
14.6.2011Country:
US
Number:
201161570110 PDate:
13.12.2011Country:
US
Classification
Categories:
A61K 9/08, A61K 9/10, A61K 47/10, A61K 47/22, A61K 47/26, A61K 31/5513, A61K 31/355, A61K 45/06, A61P 25/08
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 1.6.2022
Expires: 12.6.2023
Payer: Patice ehf.
Number: 12
Paid: 24.5.2023
Expires: 12.6.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 21.5.2024
Expires: 12.6.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 4.6.2025
Expires: 12.6.2026
Payer: Árnason Faktor ehf.